404
Protein Engineering Market Growth Analysis | 2024-2030
Protein Engineering Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2024-2030
Protein Engineering Market is segmented by Products & Services Type (Instruments, Consumables, and Software & Services), by Protein Type (Monoclonal Antibodies, Erythropoietin, Interferons, Vaccines, Colony-Stimulating Factors, Growth Hormones, Coagulation Factors, and Others), by Technology Type (Rational Protein Design, Irrational Protein Design), by End-User Type (Biopharmaceutical Companies, Contract Research Organizations, and Academic Research Institutes), and by Region (North America, Europe, Asia-Pacific, and Rest of the World).
Protein engineering is the process of altering a protein sequence to attain the desired result such as increased stability to the temperature, organic solvents, and/or extremes of pH or a change in the substrate capacity.
The protein engineering market was estimated at USD 2.55 billion in 2023.
The forecasted value of the protein engineering market is expected to reach USD 7.29 billion in 2030.
The protein engineering market is likely to grow at a CAGR of 16.15% during 2024-2030.
Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Bruker Corporation, Agilent Technologies, Inc., Waters Corporation, Danaher Corporation, Codexis, Inc., New England Biolabs, Inc., PerkinElmer, Innovagen AB, GE Healthcare, CUSABIO TECHNOLOGY LLC, Promega Corporation, Merck KGaA, GenScript Biotech Corporation, Takara Bio, Inc., Enantis S.R.O., InvivoGen, Pace Analytical, Aspira Chemical, Zymeworks, Inc., Abzena, Ltd., PhyNexus, Inc., ProteoGenix, and Creative Biolabs.
North America is expected to be the leading region in the market during the next five years.
The monoclonal antibodies and instrument segment are expected to be the most dominant segment in the market.
Some of the major factors driving the growth of the market are growing demand for biopharmaceuticals and advancements in protein engineering technologies,